The first needle-free epinephrine treatment for severe allergic reactions has received approval from Health Canada.
An epinephrine auto-injector, better known by the brand name EpiPen, is the only emergency treatment option currently on the market in Canada for allergic reactions. But that is expected to change within the next few months.
Neffy, a two-milligram nasal spray treatment, has been approved by the government agency for use by adults and children who weigh at least 30 kilograms (66 pounds), according to an April 15 press release from ALK Canada, which has acquired the distribution rights for the drug. It is expected to become available in Canadian pharmacies this summer. …